Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors

Journal of Bone and Mineral Research

Volumn 17, Issue 12, 2002, Pages 2196-2205

  Pathrose, Peterman ^a   Barmina, Olga ^b   Chang, Ching Yi ^c   McDonnell, Donald P ^c   Shevde, Nirupama K ^b   Pike, J Wesley ^b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Comodulators; LXXLL motifs; Osteocalcin; Peptides; Retinoid X receptor; Transcription; Vitamin D receptor

Indexed keywords

ALITRETINOIN; CALCITRIOL; HYBRID PROTEIN; OSTEOCALCIN; PEPTIDE; RETINOIC ACID; RETINOID X RECEPTOR; THYMIDINE KINASE; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; OLIGOPEPTIDE; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CALCIUM HOMEOSTASIS; CELL STRAIN COS1; CONTROLLED STUDY; IMMUNOPRECIPITATION; NONHUMAN; PHAGE DISPLAY; PLASMID; REPORTER GENE; TRANSACTIVATION; ANIMAL; CELL STRAIN 3T3; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSCRIPTION; MOUSE; SERODIAGNOSIS;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; CALCITRIOL; COS CELLS; MICE; OLIGOPEPTIDES; PRECIPITIN TESTS; RECEPTORS, CALCITRIOL; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0036894463     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2002.17.12.2196     Document Type: Article

References (44)

1. Evans RM 1989 The steroid and thyroid hormone receptor superfamily. Science 240:889-895.
2. Haussler MR, Whitfield GK, Haussler CA, Hsieh J-C, Thompson PD, Selznick SH, Encinas Dominguez C, Jurutka PW 1998 The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. J Bone Miner Res 13:325-349.
3. 3 receptor complementary DNA: Structural homology with thyroid hormone receptor. Proc Nat Acad Sci USA 85:3294-3298.
4. 3 receptor. Proc Natl Acad Sci USA 85:9499-9502.
5. 3. Proc Natl Acad Sci USA 86:4455-4459.
6. 3-enhancement of mouse secreted phosphoprotein 1 (Spp-1 or osteopontin) gene expression. Proc Nail Acad Sci USA 87:9995-9999.
7. Sone T, Ozono K, Pike JW 1991 A 55 kilodalton accessory factor facilitates vitamin D receptor DNA binding. Mol Endocrinol 5:1578-1586.
8. Yu V, Delsert C, Anderson B, Holloway JM, Devary OV, Naar AM, Kim SY, Boutin JM, Glass CK, Rosenfeld MG 1991 RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67:1251-1266.
9. 3 resistant rickets. Endocr Rev 20:156-188.
10. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umersono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM 1995 The nuclear receptor superfamily: The second decade. Cell 83:835-839.
11. Jin CH, Kerner SA, Hong MH, Pike JW 1996 Transcriptional activation and dimerization functions in the human vitamin D receptor. Mol Endocrinol 10:945-957.
12. Whitefield GK, Hsieh J-C, Nakajima S, MacDonald PN, Thompson PD, Jurutka PW, Haussler CA, Haussler MR 1995 A highly conserved region in the hormone binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation. Mol Endocrinol 9:1166-1179.
13. Love JD, Gooch JT, Benko S, Li C, Nagy L, Chatterjee VKK, Evans RM, Schwabe JWR 2002 The structural basis for the specificity of retinoid-X-receptor selective agonists: New insights into the role of helix H12. J Biol Chem 277: 11385-11391.
14. 3-modulated heterodimer. J Biol Chem 266:23296-23305.
15. Cheskis B. Freedman LP 1996 Modulation of nuclear receptor interactions by ligands: Kinetic analysis using surface plasmon resonance. Biochemistry 35:3309-3318.
16. Prufer K, Racz A, Lin GC, Barsony J 2000 Dimerization with retinoid X receptors promotes nuclear localization and subnuclear targeting of vitamin D receptors. J Biol Chem 275:41114-41125.
17. 3 receptor: A network of coactivator interactions. Gene 246:9-21.
18. Rachez C, Lemon BD, Suldan Z, Bromleigh V, Gamble M, Naar AM, Erdjument-Bromage H, Tempst P, Freedman LP 1999 Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398:824-828.
19. Ryu S, Zhou S, Ladurner AG, Tjian R 1999 The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Spl. Nature 397:446-450.
20. Rachez C, Gamble M, Chang CP, Atkins GB, Lazar MA, Freedman LP 2000 The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes. Mol Cell Biol 20:2718-2726.
21. 3-stimulated alkaline phosphatase in human osteosarcoma cells. Calcif Tissue Int 66:370-374.
22. Hong H, Kohli K, Garabedian MJ, Stallcup MR 1997 GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol 17:2735-2744.
23. Xu J, Liao L, Ning G, Yoshida-Komiya H, Deng C, O'Malley BW 2000 The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc Natl Acad Sci USA 97:6379-6384.
24. Zhang C, Baudino TA, Dowd DR, Tokumaru H, Wang W, MacDonald PN 2001 Ternary complexes and cooperative interplay between NCoA-62/Ski-interacting protein and steroid receptor coactivators in vitamin D receptor-mediated transcription. J Biol Chem 276:40614-40620.
25. Masuyama H, MacDonald PN 1998 Proteasome-mediated degradation of the vitamin D receptor (VDR) and a putative role for SUG1 interaction with the AF-2 domain of VDR. J Cell Biochem 71:429-440.
26. Smith CL, DeVera DG, Lamb DJ, Nawaz Z, Jiang YH, Beaudet AL, O'Malley BW 2002 Genetic ablation of the steroid receptor coactivator-ubiquitin ligase, E6-AP, results in tissue-selective steroid hormone resistance and defects in reproduction. Mol Cell Biol 22:525-535.
27. McInerney EM, Rose DW, Flynn SE, Westin S, Mullen TM, Krones A, Inostroza J, Torchia J, Nolte RT, Assa-Munt N, Milburn MV, Glass CK, Rosenfeld MG 1998 Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev 12:3357-3368.
28. Perissi V, Staszewski LM, McInerney EM, Kurokawa R, Krones A, Rose DW, Lambert MH, Milburn MV, Glass CK, Rosenfeld MG 1999 Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev 13:3198-3208.
29. Gampe RT Jr, Montana VG, Lambert MH, Miller AB, Bledsoe RK, Milburn MV, Kliewer SA, Willson TM, Xu HE 2000 Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol Cell 5:545-555.
30. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL 1998 The structural basis of estrogen receptor/ coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927-937.
31. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, Carlquist M 1997 Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753-758.
32. Chang C, Norris JD, Gron H, Paige LA, Hamilton PT, Kenan DJ, Fowlkes D, McDonnell DP 1999 Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: Discovery of peptide antagonists of estrogen receptors alpha and beta. Mol Cell Biol 19:8226-8239.
33. Hall JM, Chang CY, McDonnell DP 2000 Development of peptide antagonists that target estrogen receptor beta-coactivator interactions. Mol Endocrinol 14:2010-2023.
34. Mangelsdorf DJ, Umesono K, Kliewer SA, Borgmeyer U, Ong ES, Evans RM 1991 A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell 66:555-561.
35. McKenna NJ, Xu J, Nawaz Z, Tsai SY, Tsai MJ, O'Malley BW 1999 Nuclear receptor coactivators: Multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem Mol Biol 69:3-12.
36. 3 receptor- and retinoid X receptor-mediated gene activation in vivo. Mol Cell Biol 16:1006-1016.
37. 3 and inhibited by 9-cis-retinoic acid. Evidence for allosteric receptor interactions. J Biol Chem 273: 8483-8491.
38. Thompson PD, Remus LS, Hsieh JC, Jurutka PW, Whitfield GK, Galligan MA, Encinas Dominguez C, Haussler CA, Haussler MR 2001 Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts. J Mol Endocrinol 27:211-227.
39. DeLuca HF, Cantorna MT 2001 Vitamin D: Its role and uses in immunology. FASEB J 15:2579-2585.
40. Carlberg C, Bendik I, Wyss A, Meier E, Sturzenbecker LJ, Grippo JF, Hunziker W 1993 Two nuclear signalling pathways for vitamin D. Nature 361:657-660.
41. Carlberg C 1996 The concept of multiple vitamin D signaling pathways. J Investig Dermatol Symp Proc 1:10-14.
42. 3 receptor. Implications for allosteric influences on nuclear receptor structure and function by a DNA element. J Biol Chem 273:10338-10348.
43. Candeliere GA, Jurutka PW, Haussler MR, St.-Arnaud R 1996 A composite element binding the vitamin D receptor, retinoid X receptor alpha and a member of the CTF/NF-1 family of transcription factors mediates the vitamin D responsiveness of the c-fos promoter. Mol Cell Biol 16:584-592.
44. Mackey SL, Heymont JL, Kronenberg HM, Demay MB 1996 Vitamin D receptor binding to the negative human parathyroid hormone vitamin D response element does not require the retinoid x receptor. Mol Endocrinol 10:298-305.